DNA-PK is a DNA sensor for IRF-3-dependent innate immunity

被引:324
|
作者
Ferguson, Brian J. [1 ,2 ]
Mansur, Daniel S. [1 ]
Peters, Nicholas E. [1 ]
Ren, Hongwei [1 ,2 ]
Smith, Geoffrey L. [1 ,2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
来源
ELIFE | 2012年 / 1卷
基金
英国医学研究理事会; 英国惠康基金;
关键词
DEPENDENT PROTEIN-KINASE; NEUTROPHIL EXTRACELLULAR TRAPS; INTRACELLULAR DNA; CYTOSOLIC DNA; V(D)J RECOMBINATION; AUTOIMMUNE-DISEASE; CYTOPLASMIC DNA; DAI DLM-1/ZBP1; MAMMALIAN DNA; IN-VIVO;
D O I
10.7554/eLife.00047
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Innate immunity is the first immunological defence against pathogens. During virus infection detection of nucleic acids is crucial for the inflammatory response. Here we identify DNA-dependent protein kinase (DNA-PK) as a DNA sensor that activates innate immunity. We show that DNA-PK acts as a pattern recognition receptor, binding cytoplasmic DNA and triggering the transcription of type I interferon (IFN), cytokine and chemokine genes in a manner dependent on IFN regulatory factor 3 (IRF-3), TANK-binding kinase 1 (TBK1) and stimulator of interferon genes (STING). Both cells and mice lacking DNA-PKcs show attenuated cytokine responses to both DNA and DNA viruses but not to RNA or RNA virus infection. DNA-PK has well-established functions in the DNA repair and V(D)J recombination, hence loss of DNA-PK leads to severe combined immunodeficiency (SCID). However, we now define a novel anti-microbial function for DNA-PK, a finding with implications for host defence, vaccine development and autoimmunity.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Cryo-EM structure of human DNA-PK holoenzyme
    Yin, Xiaotong
    Liu, Mengjie
    Tian, Yuan
    Wang, Jiawei
    Xu, Yanhui
    CELL RESEARCH, 2017, 27 (11) : 1341 - 1350
  • [32] DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer
    Giguere, Vincent
    TRENDS IN CANCER, 2020, 6 (04): : 337 - 347
  • [33] Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies
    Dylgjeri, Emanuela
    McNair, Christopher
    Goodwin, Jonathan F.
    Raymon, Heather K.
    Mccue, Peter A.
    Shafi, Ayesha A.
    Leiby, Benjamin E.
    de Leeuw, Renee
    Kothari, Vishal
    McCann, Jennifer J.
    Mandigo, Amy C.
    Chand, Saswati N.
    Schiewer, Matthew J.
    Brand, Lucas J.
    Vasilevskaya, Irina
    Gordon, Nicolas
    Laufer, Talya S.
    Gomella, Leonard G.
    Lallas, Costas D.
    Trabulsi, Edouard J.
    Feng, Felix Y.
    Filvaroff, Ellen H.
    Hege, Kristin
    Rathkopf, Dana
    Knudsen, Karen E.
    CLINICAL CANCER RESEARCH, 2019, 25 (18) : 5623 - 5637
  • [34] DNA-PK promotes DNA end resection at DNA double strand breaks in G0 cells
    Fowler, Faith C.
    Chen, Bo-Ruei
    Zolnerowich, Nicholas
    Wu, Wei
    Pavani, Raphael
    Paiano, Jacob
    Peart, Chelsea
    Chen, Zulong
    Nussenzweig, Andre
    Sleckman, Barry P.
    Tyler, Jessica K.
    ELIFE, 2022, 11
  • [35] A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response
    Koch, Jonas P.
    Roth, Selina M.
    Quintin, Aurelie
    Gavini, Jacopo
    Orlando, Eleonora
    Riedo, Rahel
    Pozzato, Chiara
    Hayrapetyan, Liana
    Aebersold, Ruedi
    Stroka, Deborah M. M.
    Aebersold, Daniel M. M.
    Medo, Matus
    Zimmer, Yitzhak
    Medova, Michaela
    ONCOGENE, 2023, 42 (26) : 2113 - 2125
  • [36] DNA damage-induced inhibition of rRNA synthesis by DNA-PK and PARP-1
    Calkins, Anne S.
    Iglehart, J. Dirk
    Lazaro, Jean-Bernard
    NUCLEIC ACIDS RESEARCH, 2013, 41 (15) : 7378 - 7386
  • [37] Visualizing functional dynamicity in the DNA-dependent protein kinase holoenzyme DNA-PK complex by integrating SAXS with cryo-EM
    Hammel, Michal
    Rosenberg, Daniel J.
    Bierma, Jan
    Hura, Gregory L.
    Thapar, Roopa
    Lees-Miller, Susan P.
    Tainer, John A.
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2021, 163 : 74 - 86
  • [38] Experimental design, validation and computational modeling uncover DNA damage sensing by DNA-PK and ATM
    Flassig, R. J.
    Maubach, G.
    Taeger, C.
    Sundmacher, K.
    Naumann, M.
    MOLECULAR BIOSYSTEMS, 2014, 10 (07) : 1978 - 1986
  • [39] Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics
    Sharma, Ram
    Mishra, Anshul
    Bhardwaj, Monika
    Singh, Gurpreet
    Harahap, Larasati Vanya Indira
    Vanjani, Sakshi
    Pan, Chun Hsu
    Nepali, Kunal
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2025, 40 (01)
  • [40] DNA-PK facilitates piggyBac transposition by promoting paired-end complex formation
    Jin, Yan
    Chen, Yaohui
    Zhao, Shimin
    Guan, Kun-Liang
    Zhuang, Yuan
    Zhou, Wenhao
    Wu, Xiaohui
    Xu, Tian
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (28) : 7408 - 7413